These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17692688)

  • 1. Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports.
    Pugliese F; Ruberto F; Perrella SM; Cappannoli A; Bruno K; Martelli S; Celli P; Summonti D; D'Alio A; Tosi A; Novelli G; Morabito V; Poli L; Rossi M; Berloco PB; Pietropaoli P
    Transplant Proc; 2007; 39(6):2042-4. PubMed ID: 17692688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric acute liver failure with molecular adsorbent recirculating system treatment.
    Novelli G; Rossi M; Morabito V; Pugliese F; Ruberto F; Perrella SM; Novelli S; Spoletini G; Ferretti G; Mennini G; Berloco PB
    Transplant Proc; 2008; 40(6):1921-4. PubMed ID: 18675090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system.
    Novelli G; Rossi M; Ferretti G; Pugliese F; Ruberto F; Lai Q; Novelli S; Piemonte V; Turchetti L; Morabito V; Annesini MC; Berloco PB
    Ther Apher Dial; 2009 Oct; 13(5):404-12. PubMed ID: 19788457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One hundred sixteen cases of acute liver failure treated with MARS.
    Novelli G; Rossi M; Pretagostini M; Pugliese F; Ruberto F; Novelli L; Nudo F; Bussotti A; Corradini S; Martelli S; Berloco PB
    Transplant Proc; 2005; 37(6):2557-9. PubMed ID: 16182742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy.
    Vaquero J; Fontana RJ; Larson AM; Bass NM; Davern TJ; Shakil AO; Han S; Harrison ME; Stravitz TR; Muñoz S; Brown R; Lee WM; Blei AT
    Liver Transpl; 2005 Dec; 11(12):1581-9. PubMed ID: 16315300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of sepsis during MARS treatment in acute on chronic liver failure.
    Novelli G; Morabito V; Pugliese F; Ferretti G; Novelli S; Ianni S; Lai Q; Rossi M; Berloco PB
    Transplant Proc; 2011 May; 43(4):1085-90. PubMed ID: 21620059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it possible to gain extra waiting time to liver transplantation in acute liver failure patients using albumin dialysis?
    Koivusalo AM; Kantola T; Arola J; Höckerstedt K; Kairaluoma P; Isoniemi H
    Ther Apher Dial; 2009 Oct; 13(5):413-8. PubMed ID: 19788458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience of Mars therapy with and without transplantation in 101 patients with liver insufficiency.
    Koivusalo AM; Vakkuri A; Höckerstedt K; Isoniemi H
    Transplant Proc; 2005 Oct; 37(8):3315-7. PubMed ID: 16298584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy.
    Camus C; Lavoué S; Gacouin A; Compagnon P; Boudjéma K; Jacquelinet C; Thomas R; Le Tulzo Y
    Ther Apher Dial; 2009 Dec; 13(6):549-55. PubMed ID: 19954480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of an adult with Amanita phalloides-induced fulminant liver failure with molecular adsorbent recirculating system (MARS).
    Lionte C; Sorodoc L; Simionescu V
    Rom J Gastroenterol; 2005 Sep; 14(3):267-71. PubMed ID: 16200238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study.
    Faybik P; Bacher A; Kozek-Langenecker SA; Steltzer H; Krenn CG; Unger S; Hetz H
    Crit Care; 2006 Feb; 10(1):R24. PubMed ID: 16469128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
    Gaspari R; Cavaliere F; Sollazzi L; Perilli V; Melchionda I; Agnes S; Gasbarrini A; Avolio AW
    Transplant Proc; 2009; 41(1):253-8. PubMed ID: 19249528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure.
    Lee KH; Lee MK; Sutedja DS; Lim SG
    Liver Int; 2005 Oct; 25(5):973-7. PubMed ID: 16162155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is MARS system enough for A. phalloides-induced liver failure treatment?
    Sorodoc L; Lionte C; Sorodoc V; Petris O; Jaba I
    Hum Exp Toxicol; 2010 Oct; 29(10):823-32. PubMed ID: 20179021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients.
    Pugliese F; Novelli G; Poli L; Levi Sandri GB; Di Folco G; Ferretti S; Morabito V; Ruberto F; Berloco PB
    Transplant Proc; 2008; 40(6):1925-8. PubMed ID: 18675091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intracranial pressure monitoring in children with fulminant hepatic failure].
    Paiva WS; de Andrade AF; Amorim RL; Figueiredo EG; Matushita H; Teixeira MJ
    Rev Neurol; 2009 Feb 1-15; 48(3):134-6. PubMed ID: 19206060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients.
    Kantola T; Koivusalo AM; Höckerstedt K; Isoniemi H
    Transpl Int; 2008 Sep; 21(9):857-66. PubMed ID: 18510596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial liver support system in acute liver failure patients waiting liver transplantation.
    Montejo González JC; Catalán González M; Meneu Díaz JC; Moreno Elola-Olaso A; De la Cruz J; Moreno González E
    Hepatogastroenterology; 2009; 56(90):456-61. PubMed ID: 19579620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
    Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
    Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mars and Prometheus: our clinical experience in acute chronic liver failure.
    Faenza S; Baraldi O; Bernardi M; Bolondi L; Coli L; Cucchetti A; Donati G; Gozzetti F; Lauro A; Mancini E; Pinna AD; Piscaglia F; Rasciti L; Ravaioli M; Ruggeri G; Santoro A; Stefoni S
    Transplant Proc; 2008 May; 40(4):1169-71. PubMed ID: 18555140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.